Navigation Links
Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
Date:12/21/2007

BURLINGTON, Mass., Dec. 21 /PRNewswire/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced an agreement with The Gillette Company (a wholly owned subsidiary of The Procter and Gamble Company (NYSE: PG)) to extend the Launch Decision of a home-use, light-based hair removal device for women until no later than February 29, 2008. Under the existing Development and License Agreement entered into by Palomar and Gillette on February 14, 2003 and as Amended and Restated on February 14, 2007, Gillette had until January 7, 2008 to make the Launch Decision. During this extension period, Palomar and Gillette have agreed to enter into negotiations for a new agreement to replace the existing one. The goal of a new agreement would be to enable the parties to continue to work together to fully capitalize on the market potential. Although no assurances can be given as to the outcome of these negotiations, it is anticipated that a new agreement would include the release of Palomar from exclusivity and the retention by Gillette of non-exclusive rights to Palomar's technology and intellectual property. In return for a release from exclusivity, Palomar anticipates that there would be a reduction in the percentage of net sales that Gillette pays to Palomar and a change from annual payments under the existing agreement to reduced calendar quarterly payments for a certain period. There can be no assurances that Palomar and Gillette will reach
'/>"/>

SOURCE Palomar Medical Technologies Inc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast
2. Weight-Loss Surgeries Extend Lives
3. Siemens Extends Tender Offer for Acquisition of Dade Behring
4. Global Med Technologies(R) Extends Its Worldwide Outreach
5. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
6. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
7. Cancer control in Europe works; now it is time to extend it to poorer countries
8. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
9. NIH/NCI renews and extends nationwide license for Genomatix software and databases
10. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
11. Summer Temperatures Linger, Extend Threat of Parasites

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--TheBayAreaAirQualityManagementDistrictisissui... Alert forThursday,November26,2009whichbansburn...thindoorsandoutdoors. ,, "Cold,stillweatherwill...roadbent,executiveofficeroftheAirDistrict."We,reas...borsandfellowcommunitymembersthisThanksgiving,andn...
(Date:11/25/2009)...cancer who were treated with cisplatin-based chemo...urological side effects and Raynaud-like phenomena... according to a new study published online Novembe...ute . , Marianne Brydy, M.D., of the Department ...gen, Norway, and colleagues conducted a cross-sect...
(Date:11/25/2009)... out of a collaboration between UCLA engineers and...arly 10 million Americans who suffer from peripher...ng of the arteries, peripheral arterial disease, o...rrowed arteries reduce blood flow to the limbs. Th...disease, heart attack and stroke, and its progress...
(Date:11/25/2009)...hort to draw definite conclusions, experts say, ,...- In diabetic patients with blocked coronary arter... at one year whether patients undergo bypass surge...rs report. , Bypass surgery has been the standa...rtery disease. However, less invasive approaches s...
(Date:11/25/2009)... and treatment clinics to resume Monday, Nov. 30 ...er 25, 2009 -- Centegra Health System is continuin...ots at four Centegra Primary Care (CPC) vaccinatio...rived. The clinics are at CPC sites in Huntley, Wo... as follows: ,   From 4:30 to 7:30 p.m...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... Bias Correction of Familial Risk Estimates Incr...r Common Cancers , The relative risk of familial... account for a known potential bias in a large coh... have used the Swedish Cancer Registry and the Swe...
...espite recommendations from various groups, many h... TUESDAY, Sept. 9 (HealthDay News) -- According to... report giving formula sample packs to new moms, e... Adolescent Medicine , surveyed 1,295 hospitals in...
...EXFORD, Penn., Sept. 9 Millennium Pharmacy System...hnology enabled pharmacy,solutions to senior healt...of Richard Scardina as Chief Executive Officer. Mr...erving as an executive,with Caremark Rx, Inc., Ga...
... PHILADELPHIA - Researchers from the University o...a key step in the formation and suppression of e...east, head, and neck. By studying human tissue sam...t to contribute to the early stages of cancer deve...
...THENS, Ga., Sept. 9 ArunA Biomedical, Inc., the f... cell derived products and,services, announced tod...ion CFO, Harold "Bud" Ingalls, to its Board of Dir...arly 20 years of experience as a chief financial o...
...lan Challenges Policy-makers, Physicians, Patients...SHINGTON, Sept. 9 In an address today at,the Nati...E: MHS ) Chairman,and CEO, David B. Snow Jr. unve... problem. Unifying the strengths,of both the publi...
Other Medicine News:Health News:Also in the Sept. 9 JNCI 2Health News:Also in the Sept. 9 JNCI 3Health News:Formula Samples Hinder Breast-Feeding Efforts 2Health News:Penn researchers identify natural tumor suppressor 2Health News:ArunA Biomedical Names Harold Ingalls to its Board of Directors 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 3Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 4
(Date:11/25/2009)...ndsResearchGroup,Inc.releasedWave1ofits LaunchTre...syndicatedmarketresearchprojecttrackingthelaunchof...roughthefirstsixmonthsofavailability.Eachwaveofthe...ermatologistsandqualitativeinformationfromasubseto...touse,typicalpatienttypes,productperceptions,promo...
(Date:11/25/2009)...--RegadoBiosciences,aprivatelyheldcompanyleadingth...rolagents,announcedthatDavidMazzo,PhD,CEOandPresid...lthCareConferenceattheNewYorkPalaceHotelinNewYorkC...onTuesday,December1andwillincludeanoverviewoftheCo...gram,theanticoagulantsystem,REG1.Thehealthcareindu...
(Date:11/25/2009).../--SwissrayInternational,Inc.aleadingmanufacturero...odaythatitsoperationshavebeenacquiredbyaprivateSwi...smedicalimagingbrand.Theacquisitionincludedallasse...ntory.After25yearsofsuccessandgrowthSwissrayisnowp...tswithstableandsteadygrowth. ,, "Swissrayhaslon...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2SpectraScience Receives FDA Approval for Enhancements to WavSTAT 28R 29 Optical Biopsy System 57419 1SpectraScience Receives FDA Approval for Enhancements to WavSTAT 28R 29 Optical Biopsy System 57419 2Scars of Bullying Linger 57417 1InVitria Cell Culture Product Line to Headline PEACe 57415 1InVitria Cell Culture Product Line to Headline PEACe 57415 2
... Agennix Incorporated today announced,the publica...rial with,talactoferrin alfa in patients who had f...c renal cell carcinoma (RCC). Results from the stu...journal ,Cancer, (volume,113, number 1), demonstra...rable toxicity profile, and is a promising candida...
...innon, Founder of HEAR Music, NEW YORK, June 30 ...eamless way for people to receive music from artis...h (RED). By applying the (RED),idea to music this ...ists,and labels and buy life-saving medicine for t...founder of HEAR Music and former Vice President of...
Other Medicine Technology:Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 2Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 4Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 5(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 2(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 3
Streck-Kleen Concentrate Enzymatic Cleanser
Streck-CD3500 Hemoglobin/Lyse Lytic Reagent
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-Diluent IIIA Balanced Electrolyte Solution
Medicine Products: